Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Integrated Analysis Revealed an Inflammatory Cancer-Associated Fibroblast-Based Subtypes with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Bladder Cancer Patients. | Int J Mol Sci | 2022 | 36555612 | PubTator, text mining | PubMed |
| Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing. | Genes (Basel) | 2022 | 36553468 | PubTator, text mining | PubMed |
| Noncoding RNAs Are Promising Therapeutic Targets for Diabetic Retinopathy: An Updated Review (2017-2022). | Biomolecules | 2022 | 36551201 | PubTator, text mining | PubMed |
| Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II. | Ann Clin Case Rep | 2022 | 36540866 | PubTator, text mining | PubMed |
| Emerging pharmacological treatment options for MAFLD. | Ther Adv Endocrinol Metab | 2022 | 36533188 | PubTator, text mining | PubMed |
| Development of a copper metabolism-related gene signature in lung adenocarcinoma. | Front Immunol | 2022 | 36524120 | PubTator, text mining | PubMed |
| Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma-a bioinformatics analysis. | Transl Androl Urol | 2022 | 36507474 | PubTator, text mining | PubMed |
| Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches. | Int J Mol Sci | 2022 | 36499287 | PubTator, text mining | PubMed |
| Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation. | Cancers (Basel) | 2022 | 36497411 | PubTator, text mining | PubMed |
| Engineering chimeric antigen receptor T cells for solid tumour therapy. | Clin Transl Med | 2022 | 36495108 | PubTator, text mining | PubMed |
| OMICS Approaches Evaluating Keloid and Hypertrophic Scars. | Int J Inflam | 2022 | 36483731 | PubTator, text mining | PubMed |
| Caulerpa racemosa extract inhibits HeLa cancer cells migration by altering expression of epithelial-mesenchymal transition proteins. | Front Chem | 2022 | 36479442 | PubTator, text mining | PubMed |
| MMP1 acts as a potential regulator of tumor progression and dedifferentiation in papillary thyroid cancer. | Front Oncol | 2022 | 36479070 | PubTator, text mining | PubMed |
| A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer. | Front Oncol | 2022 | 36465388 | PubTator, text mining | PubMed |
| Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment. | Front Oncol | 2022 | 36457492 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer. | Theranostics | 2022 | 36438499 | PubTator, text mining | PubMed |
| The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth. | Cell Oncol (Dordr) | 2022 | 36435866 | PubTator, text mining | PubMed |
| Fluid Biomarkers in HPV and Non-HPV Related Oropharyngeal Carcinomas: From Diagnosis and Monitoring to Prognostication-A Systematic Review. | Int J Mol Sci | 2022 | 36430813 | PubTator, text mining | PubMed |
| The Oncopig as an Emerging Model to Investigate Copper Regulation in Cancer. | Int J Mol Sci | 2022 | 36430490 | PubTator, text mining | PubMed |
| Insight into the Spatial Arrangement of the Lysine Tyrosylquinone and Cu2+ in the Active Site of Lysyl Oxidase-like 2. | Int J Mol Sci | 2022 | 36430446 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=28